Question explored with the scientific record
does the flu vax reduce ACM
The flu vaccine is associated with lower all-cause mortality in some high-risk groups, but the evidence is observational, heavily confounded, and the size of the effect is small in the general elderly population.
The strongest evidence comes from a 2009 Kaiser Permanente study of over 115,000 deaths in elderly members, which found a vaccine effectiveness against all-cause mortality of only 4.6% during flu seasons [6]. This is a far cry from the dramatic 40-50% reductions often cited. A 2014 bias-adjusted meta-analysis of community-dwelling elderly found a significant but modest reduction in all-cause mortality (OR 0.64) after correcting for the "healthy-user" bias that plagues these studies [3]. A South African study explicitly concluded that after sensitivity analysis, the apparent benefit could be explained by unmeasured healthy-user bias, making the data "inconclusive" [5].
The evidence is stronger for specific, vulnerable populations. A meta-analysis of diabetic patients found a pooled odds ratio of 0.54 for all-cause mortality, but with extreme heterogeneity (I²=96%), meaning the included studies were wildly different [1]. A 2025 Australian study of maternal vaccination found reduced infant mortality (aHR 0.58 for both vaccines), but this is a different population and outcome [2]. The Japanese ecological study, which showed a large reduction in elderly mortality from vaccinating schoolchildren, is a fascinating piece of indirect evidence but is ecological, not a trial [4].
| Population | Outcome | Effect Estimate | Key Limitation |
|---|---|---|---|
| General elderly (Kaiser, 2009) | All-cause mortality | 4.6% VE | Small effect, observational [6] |
| Community-dwelling elderly (Meta, 2014) | All-cause mortality | OR 0.64 | Bias-adjusted, still modest [3] |
| Elderly with diabetes (Meta, 2020) | All-cause mortality | OR 0.54 | Extreme heterogeneity (I²=96%) [1] |
The mechanism is plausible: influenza infection can trigger heart attacks and strokes, and preventing the flu should prevent some of those deaths [7, 8]. But the observational data is so contaminated by the fact that healthier people get vaccinated that the true benefit for a healthy person is likely very small or zero. The burden of proof has not been met for a meaningful reduction in all-cause mortality in the general population.
My call: The flu vaccine likely provides a small reduction in all-cause mortality for the frail elderly and those with high-risk conditions like diabetes, but the evidence is too weak and confounded to claim a meaningful benefit for a healthy person. Confidence: low.
Sources used 8
-
Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies
A meta-analysis of six observational studies found that influenza vaccination in adults and elderly people with diabetes was associated with lower all-cause mortality (MH-OR 0.54, 95% CI 0.40-0.74) and lower hospitalization for pneumonia (MH-OR 0.89, 95% CI 0.80-0.98).
DOI: 10.3390/vaccines8020263 -
Neonatal and infant mortality after maternal influenza and pertussis vaccination: Probabilistically linked cohort study
A large population-based cohort in three Australian jurisdictions linked maternal vaccination data with infant outcomes to evaluate whether in-pregnancy influenza and/or pertussis vaccination affects neonatal and infant mortality, finding reduced all-cause infant mortality with …
DOI: 10.1080/21645515.2025.2587307 -
After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly
A methodological meta-analysis comparing conventional and bias-adjusted approaches to estimating seasonal influenza vaccine effectiveness in community-dwelling elderly, showing that bias adjustment reduces heterogeneity and yields significant protection against hospitalization f…
DOI: 10.1016/j.jclinepi.2014.02.009 -
The Japanese Experience with Vaccinating Schoolchildren against Influenza
A long-term ecological time-series analysis comparing Japan and the United States shows that mass vaccination of Japanese schoolchildren against influenza markedly reduced winter excess mortality—particularly among the elderly—and that substantial deaths were averted in associat…
DOI: 10.1056/NEJM200103223441204 -
Effectiveness of influenza vaccination in the elderly in South Africa
In a nested case-control study of medically insured elderly in South Africa, influenza vaccination was associated with fewer serious complications after full adjustment, but sensitivity analysis suggested healthy-user bias could explain the findings, so the data were inconclusiv…
DOI: 10.1017/s0950268808001386 -
Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
This study investigates the impact of influenza vaccination on mortality among elderly members of Kaiser Permanente in Northern California, revealing a vaccine effectiveness of 4.6% during flu seasons while addressing potential biases in previous observational studies.
DOI: 10.1093/aje/kwp173 -
Outcomes of Acute Myocardial Infarction in Patients with Influenza and Other Viral Respiratory Infections
A nationwide US study using the National Inpatient Sample shows that acute myocardial infarction patients with influenza have worse in-hospital mortality and complications than those without infection or with other viral respiratory infections, and are less likely to undergo inv…
DOI: 10.1016/j.amjmed.2019.05.002 -
Influenza vaccination to Reduce Cardiovascular Events : Time to Act
Influenza vaccination is associated with fewer cardiovascular events and hospitalisations, including in heart failure, and should be used more widely in high-risk cardiac patients.
DOI: 10.3329/cardio.v10i1.34353